Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/8/24 16:22 | 4/4/24 | HLVX | Health | BioPrd | Biological Products, (No Diag | Frazier Life Sciences X, L.P. | WA | T | P | 128 | 14.50 | 0 | 9 | 0 | 8,544 | D | |||||||||||||||
4/1/24 16:08 | 3/28/24 | HLVX | Health | BioPrd | Biological Products, (No Diag | McLoughlin Sean | MA | O | COO | P | 21 | 16.98 | 0 | 1 | New | 1 | D | ||||||||||||||
5/3/22 16:23 | 5/3/22 | HLVX | Health | BioPrd | Biological Products, (No Diag | Frazier Life Sciences X, L.P. | WA | T | P.d | 30,000 | 17.00 | 0 | 1,765 | 26 | 8,535 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |